Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Daniel F. Pauly"'
Autor:
Qi Chen, Steven E. Reis, Candace Kammerer, Wendy Craig, Dennis M. McNamara, Richard Holubkov, Barry L. Sharaf, George Sopko, Daniel F. Pauly, C. Noel Bairey Merz, M. Ilyas Kamboh for the WISE study group
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 4, Pp 801-807 (2011)
Atherosclerosis is the major cause of coronary artery disease (CAD), and oxidized LDL (oxLDL) is believed to play a key role in the initiation of the atherosclerotic process. Recent studies show that inflammation and autoimmune reactions are also rel
Externí odkaz:
https://doaj.org/article/899e7e9a98064a3697cac6da8d5a11a7
Autor:
Yuji Nagatomo, Dennis M. McNamara, Jeffrey D. Alexis, Leslie T. Cooper, G. William Dec, Daniel F. Pauly, Richard Sheppard, Randall C. Starling, W.H. Wilson Tang, Karen Janosko, Charles McTiernan, Barry London, Karen Hanley-Yanez, John Gorcsan, Hidekazu Tanaka, Mathew Suffoletto, Cynthia Oblak, Annette McNallan, LuAnne Koenig, Paul Mather, Natalie Pierson, Sharon Rubin, Yanique Bell, Alicia Ervin, John Boehmer, Patricia Frey, Jeffrey Alexis, Janice Schrack, Pam LaDuke, Guillermo Torre-Amione, Jeannie Arredondo, Pamela C. Smith, Stephanie Fuoco, Ilan S. Wittstein, Elayne Breton, Vinay Thohan, Deborah Wesley, Diane Cocca-Spofford, David W. Markham, Lynn Fernandez, Colleen Debes, Mark J. Zucker, Laura Adams, Peter Liu, Judith Renton, Jagat Narula, Byron Allen, Elizabeth Westberg
Publikováno v:
Journal of the American College of Cardiology. 69:968-977
Background Among various cardiac autoantibodies (AAbs), those recognizing the β 1 -adrenergic receptor (β 1 AR) demonstrate agonist-like effects and induce myocardial damage that can be reversed by β-blockers and immunoglobulin G3 (IgG3) immunoads
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c96e5f783e621015657fb8888963dc91
https://doi.org/10.1016/j.jacc.2016.11.067
https://doi.org/10.1016/j.jacc.2016.11.067
Autor:
Daniel F. Pauly
Publikováno v:
Cardiology Clinics. 32:145-149
In patients with acute decompensated heart failure, an important first step is to determine the factors that precipitated the deterioration in cardiac function or increased the body’s demand. Such factors can include myocardial ischemia, poorly con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a84f132b547ad664bdb1aaa77e2c423
https://doi.org/10.1016/j.ccl.2013.09.011
https://doi.org/10.1016/j.ccl.2013.09.011
Autor:
Heather J. Ross, Jon A. Kobashigawa, James A. Hill, Randall C. Starling, Patricia Lopez, Howard J. Eisen, Shoei-Shen Wang, Stephen J. Nicholls, Bernard Cantin, Gaohong Dong, A Ivus Substudy Investigators, Daniel F. Pauly
Publikováno v:
JACC: Heart Failure. 1:389-399
Objectives A pre-planned substudy of a larger multicenter randomized trial was undertaken to compare the efficacy of everolimus with reduced-dose cyclosporine in the prevention of cardiac allograft vasculopathy (CAV) after heart transplantation to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c728a15cc3cd67e3f4091818e8f7debe
https://doi.org/10.1016/j.jchf.2013.07.002
https://doi.org/10.1016/j.jchf.2013.07.002
Autor:
Howard J. Eisen, Luciano Potena, Anne Keogh, Andreas Zuckermann, Daniel F. Pauly, Jon A. Kobashigawa, Mauro Rinaldi, Shoei-Shen Wang, Bernard Cantin, Randall C. Starling, A. Van Bakel, Hans B. Lehmkuhl, Heather J. Ross, Gaohong Dong, Stephan Hirt, C. Cornu-Artis, Abdallah G. Kfoury, Patricia Lopez, Greg Ewald
Publikováno v:
American Journal of Transplantation. 13:1203-1216
In an open-label, 24-month trial, 721 de novo heart transplant recipients were randomized to everolimus 1.5 mg or 3.0 mg with reduced-dose cyclosporine, or mycophenolate mofetil (MMF) 3 g/day with standard-dose cyclosporine (plus corticosteroids ± i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1efcfc29a0e14b49184ce2096d17dfe
https://doi.org/10.1111/ajt.12181
https://doi.org/10.1111/ajt.12181
Autor:
Yuji, Nagatomo, Dennis M, McNamara, Jeffrey D, Alexis, Leslie T, Cooper, G William, Dec, Daniel F, Pauly, Richard, Sheppard, Randall C, Starling, W H Wilson, Tang, Elizabeth, Westberg
Publikováno v:
Journal of the American College of Cardiology. 69(8)
Among various cardiac autoantibodies (AAbs), those recognizing the βThe goal of this study was to investigate the role of βPeripheral blood samples were drawn at enrollment in patients with recent-onset cardiomyopathy (left ventricular ejection fra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dded11cb19d3b55a96bee371793dca38
https://pubmed.ncbi.nlm.nih.gov/28774389
https://pubmed.ncbi.nlm.nih.gov/28774389
Autor:
Richard, Sheppard, Paul J, Mather, Jeffrey D, Alexis, Randall C, Starling, John P, Boehmer, Vinay, Thohan, Daniel F, Pauly, David W, Markham, Mark, Zucker, Kevin E, Kip, Dennis M, McNamara, Elizabeth, Westberg
Publikováno v:
Journal of Cardiac Failure. 18:675-681
Background Given the potential for recovery in recent onset nonischemic cardiomyopathy (ROCM), the timing and need for implantable cardioverter-defibrillator (ICDs) remains controversial. We examined the utilization of ICDs and the impact on survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aed496a55c5834234410d9732d6de07
https://doi.org/10.1016/j.cardfail.2012.07.004
https://doi.org/10.1016/j.cardfail.2012.07.004
Autor:
C. Noel Bairey Merz, Rhonda M. Cooper-DeHoff, Carl J. Pepine, Sheryl F. Kelsey, George Sopko, Barry M. Sharaf, Eileen M. Handberg, Daniel F. Pauly, B. Delia Johnson, R. David Anderson, Karen M. Smith
Publikováno v:
American Heart Journal. 162:678-684
Background We investigated the role of the renin-angiotensin system in women with signs and symptoms of ischemia without obstructive coronary artery disease (CAD). Although microvascular dysfunction has been suggested to explain this syndrome and rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::413ff860f9f82a4d399dc80cb11270b4
https://doi.org/10.1016/j.ahj.2011.07.011
https://doi.org/10.1016/j.ahj.2011.07.011
Autor:
Michael Pacanowski, Daniel F. Pauly, Julie A. Johnson, Taimour Y. Langaee, Reginald F. Frye, Jaekyu Shin
Publikováno v:
Pharmacotherapy. 31:942-950
Study Objective. To assess the effects of the cytochrome P450 (CYP) 3A genotype, CYP3A5, on atorvastatin pharmacokinetics and its interaction with clarithromycin. Design. Prospective, two-phase, randomized-sequence, open-label pharmacokinetic study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917177eb955363191270c53325155281
https://doi.org/10.1592/phco.31.10.942
https://doi.org/10.1592/phco.31.10.942
Autor:
Mariell, Jessup, Barry, Greenberg, Donna, Mancini, Thomas, Cappola, Daniel F, Pauly, Brian, Jaski, Alex, Yaroshinsky, Krisztina M, Zsebo, Howard, Dittrich, Roger J, Hajjar, Daniel R, Salomon
Publikováno v:
Circulation. 124:304-313
Background— Adeno-associated virus type 1/sarcoplasmic reticulum Ca 2+ -ATPase was assessed in a randomized, double-blind, placebo-controlled, phase 2 study in patients with advanced heart failure. Methods and Results— Thirty-nine patients receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f29a2a5061e8a2e5d1bee3998dee7e
https://doi.org/10.1161/circulationaha.111.022889
https://doi.org/10.1161/circulationaha.111.022889